Latest filing published 12 Jun 2025 for OptimizeRx Corp.
Cathy Klema has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Pharmaceutical Product Development Inc, Watson Pharmaceuticals Inc and Allergan plc. We count 72 filings; the first trade dates from 3 January 2006 and the latest from 11 June 2025.
On the market, this insider has only sold: 34 sales, €2.3M in total. The rest of the record consists of 27 share grants and 7 option exercises.
The newest entry dates from 12 June 2025: a share grant, in OptimizeRx Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 66 declarations